Pharma

May 14 2018

Pharma Bro – Martin Shkreli found guilty in securities fraud trial – Chicago Tribune, epic pharma.#Epic #pharma

‘Pharma Bro’ Martin Shkreli found guilty in securities fraud trial Prosecutors said Shkreli ran what was effectively a Ponzi scheme, defrauding investors by exaggerating his own credentials. (July 27, 2017) Prosecutors said Shkreli ran what was effectively a Ponzi scheme, defrauding investors by exaggerating his own credentials. (July 27, 2017) Martin Shkreli, the eccentric former pharmaceutical CEO notorious for a price-gouging scandal and for his snide Pharma Bro persona on social media, was convicted Friday on federal charges he deceived investors in a pair of failed hedge funds. A Brooklyn jury deliberated five days before finding Shkreli guilty on three …

May 13 2018

What – s ahead for Epic? MedCity News, epic pharma.#Epic #pharma

MedCity News Wilson Sonsini tops Life Sciences Law Firm Index for 2nd straight year What s ahead for Epic? An organization has to keep with the times if it wants to succeed. During the Cool Stuff Ahead session at this year s Epic Users’ Group Meeting, multiple leaders discussed how the Verona, Wisconsin-based vendor is doing just that. Sumit Rana, senior vice president of research and development, took the audience on a tour of what his company has been working on, from revenue cycle progressions to population health strategies. One of the biggest announcements of the session was that Epic …

Jan 15 2018

Pharma bro Martin Shkreli convicted in federal fraud case, epic pharma.#Epic #pharma

Pharma bro Martin Shkreli found guilty of 3 of 8 charges, including securities fraud A federal jury Friday found notorious “Pharma bro” Martin Shkreli guilty of three counts of securities fraud — but acquitted him of five other criminal counts related to hedge funds investors and a drug company he founded. div > div.group > p:first-child”> The split verdict in Shkreli’s trial came at about 2:37 p.m. on the fifth day of jury deliberations, after a more-than-month-long trial in Brooklyn, New York, federal court. While the seven-woman, five-man jury clearly accepted some of the prosecution’s evidence, it rejected other parts …

Jan 8 2018

Epic pharma #promius #pharma

#epic pharma # WELCOME TO EPIC EPIC PHARMA began operations in mid-2008 by purchasing the Sandoz facility located in Laurelton, NY. We are dedicated to developing and manufacturing generic prescription drugs in a variety of therapeutic categories in tablet, capsule and powder forms. In addition to internal drug development and manufacture, we also offer contract manufacturing services with an emphasis on quality, customer satisfaction and low cost. We have a proven track record as we are the largest contract manufacturer in the United States for a large pharmaceutical company. Epic Pharma’s continues to diversify it’s portfolio by adding new products …

Jan 8 2018

Humanwell Healthcare, PuraCap Acquire Epic Pharma – Contract Pharma #research #pharma

#epic pharma # Related Breaking News Humanwell Healthcare Group and PuraCap Pharmaceutical have acquired Epic Pharma for $550 million. The acquisition will further establish Humanwell and PuraCap in the U.S. generics market and expand their existing commercial and manufacturing capabilities. The acquisition of Epic will provide a robust generic product portfolio, which includes tablets, 2-piece capsules and powder dosage form products as well as a future product portfolio that will include a series of controlled drug substances. Humanwell and PuraCap will acquire Epic s balanced and diversified portfolio, which currently consists of 15 marketed generic products and a pipeline of …

Dec 26 2017

Elite Pharmaceuticals and Epic Pharma Enter Into a Sales and Distribution Licensing Agreement for Abuse-Deterrent ELI-200 Other OTC: ELTP #sandoz #pharma

#epic pharma # Elite Pharmaceuticals and Epic Pharma Enter Into a Sales and Distribution Licensing Agreement for Abuse-Deterrent ELI-200 June 09, 2015 08:00 ET | Source: Elite Pharmaceuticals, Inc. NORTHVALE, N.J. June 9, 2015 (GLOBE NEWSWIRE) — Elite Pharmaceuticals, Inc. (“Elite” or the “Company”) (OTCQB:ELTP) announced today that it has entered into a sales and distribution licensing agreement with Epic Pharma LLC for ELI-200 (the “License”), an abuse-deterrent opioid utilizing Elite’s proprietary pharmacological abuse-deterrent technology. Epic will be responsible for sales and marketing of ELI-200, and Elite will be responsible for the manufacture of the product. Epic will pay Elite …

Dec 19 2017

Humanwell Healthcare Group and PuraCap Pharmaceutical LLC to Acquire Epic Pharma, LLC #major #pharmaceutical #companies

#epic pharma # Humanwell Healthcare Group and PuraCap Pharmaceutical LLC to Acquire Epic Pharma, LLC The acquisition of Epic will provide a robust generic product portfolio which includes tablets, 2-piece capsules and powder dosage form products as well as a future product portfolio that will include a series of controlled drug substances. Humanwell and PuraCap will acquire Epic’s balanced and diversified portfolio, which currently consists of 15 marketed generic products and a pipeline of 37 products, and this acquisition will complement PuraCap’s own R D efforts by utilizing Epic’s strengths in the manufacture and development of controlled drug substances and …

Nov 24 2017

Epic pharma #piramal #pharma

#epic pharma # WELCOME TO EPIC EPIC PHARMA began operations in mid-2008 by purchasing the Sandoz facility located in Laurelton, NY. We are dedicated to developing and manufacturing generic prescription drugs in a variety of therapeutic categories in tablet, capsule and powder forms. In addition to internal drug development and manufacture, we also offer contract manufacturing services with an emphasis on quality, customer satisfaction and low cost. We have a proven track record as we are the largest contract manufacturer in the United States for a large pharmaceutical company. Epic Pharma’s continues to diversify it’s portfolio by adding new products …

Nov 15 2017

Elite Pharmaceuticals and Epic Pharma Enter Into a Sales and Distribution Licensing Agreement for Abuse-Deterrent ELI-200 Other OTC: ELTP #ono #pharma

#epic pharma # Elite Pharmaceuticals and Epic Pharma Enter Into a Sales and Distribution Licensing Agreement for Abuse-Deterrent ELI-200 June 09, 2015 08:00 ET | Source: Elite Pharmaceuticals, Inc. NORTHVALE, N.J. June 9, 2015 (GLOBE NEWSWIRE) — Elite Pharmaceuticals, Inc. (“Elite” or the “Company”) (OTCQB:ELTP) announced today that it has entered into a sales and distribution licensing agreement with Epic Pharma LLC for ELI-200 (the “License”), an abuse-deterrent opioid utilizing Elite’s proprietary pharmacological abuse-deterrent technology. Epic will be responsible for sales and marketing of ELI-200, and Elite will be responsible for the manufacture of the product. Epic will pay Elite …

Nov 5 2017

Humanwell and PuraCap to acquire Epic Pharma for $550m – Pharmaceutical Technology #q #pharma

#epic pharma # Humanwell and PuraCap to acquire Epic Pharma for $550m Humanwell Healthcare Group and PuraCap Pharmaceutical have agreed to acquire US-based Epic Pharma in a deal valued at $550m. With this investment, Humanwell and PuraCap will expand their presence in the US generics market and existing commercial and manufacturing capabilities. The deal includes Epic’s generic product portfolio which includes tablets, two-piece capsules and powder dosage form products, as well as a future product portfolio that will include a series of controlled drug substances. Epic’s portfolio consists of 15 marketed generic products and a pipeline of 37 products. The …